Calcium Channel Blocker, Azelnidipine, Reduces Lipid Hydroperoxides in Patients with Type 2 Diabetes Independent of Blood Pressure

Chie OHMURA; Hirotaka WATADA; Tomoaki SHIMIZU; Ken SAKAI; Hiroshi UCHINO; Yoshio FUJITANI; Akio KANAZAWA; Takahisa HIROSE; Ryuzo KAWAMORI

doi:10.1507/endocrj.k07-063

Calcium Channel Blocker, Azelnidipine, Reduces Lipid Hydroperoxides in Patients with Type 2 Diabetes Independent of Blood Pressure

Endocrine Journal ◽

10.1507/endocrj.k07-063 ◽

2007 ◽

Vol 54 (5) ◽

pp. 805-811 ◽

Cited By ~ 12

Author(s):

Chie OHMURA ◽

Hirotaka WATADA ◽

Tomoaki SHIMIZU ◽

Ken SAKAI ◽

Hiroshi UCHINO ◽

...

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Lipid Hydroperoxides

Download Full-text

Effect of Fixed‐Dose ACE‐Inhibitor/Calcium Channel Blocker Combination Therapy vs. ACE‐Inhibitor Monotherapy on Arterial Compliance in Hypertensive Patients With Type 2 Diabetes

Preventive Cardiology ◽

10.1111/j.1520-037x.2005.3535.x ◽

2005 ◽

Vol 8 (2) ◽

pp. 87-92 ◽

Cited By ~ 13

Author(s):

Nathaniel Winer ◽

Amy Folker ◽

Julie A. Murphy ◽

Elena Hung ◽

Mara Bard ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Ace Inhibitor ◽

Channel Blocker ◽

Arterial Compliance ◽

Fixed Dose ◽

Hypertensive Patients

Download Full-text

Statin, Calcium Channel Blocker and Beta Blocker Therapy May Decrease the Incidence of Tuberculosis Infection in Elderly Taiwanese Patients with Type 2 Diabetes

International Journal of Molecular Sciences ◽

10.3390/ijms160511369 ◽

2015 ◽

Vol 16 (12) ◽

pp. 11369-11384 ◽

Cited By ~ 15

Author(s):

Mei-Yueh Lee ◽

Kun-Der Lin ◽

Wei-Hao Hsu ◽

Hsiu-Ling Chang ◽

Yi-Hsin Yang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Beta Blocker ◽

Channel Blocker ◽

Tuberculosis Infection ◽

Blocker Therapy ◽

Beta Blocker Therapy

Download Full-text

Effect of Calcium Channel Blocker Amlodipine on the Intimal-Medial Thickness of Carotid Arterial Wall in Type 2 Diabetes

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199906000-00009 ◽

1999 ◽

Vol 33 (6) ◽

pp. 894-896 ◽

Cited By ~ 30

Author(s):

Hiroyuki Koshiyama ◽

Satsuki Tanaka ◽

Jun Minamikawa

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Arterial Wall ◽

Channel Blocker ◽

Intimal Medial Thickness ◽

Carotid Arterial

Download Full-text

The L/N-Type Calcium Channel Blocker, Cilnidipine, Reduces Heart Rate and Albuminuria in Patients with Type 2 Diabetes

Journal of International Medical Research ◽

10.1177/147323001003800222 ◽

2010 ◽

Vol 38 (2) ◽

pp. 602-610 ◽

Cited By ~ 8

Author(s):

M Tanaka

Keyword(s):

Type 2 Diabetes ◽

Heart Rate ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker

Download Full-text

In Half of Hypertensive Diabetics, Co-Administration of a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor Achieved a Target Blood Pressure of <130/80mmHg: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes (ATTEST) Study

Hypertension Research ◽

10.1291/hypres.31.1499 ◽

2008 ◽

Vol 31 (8) ◽

pp. 1499-1508 ◽

Cited By ~ 8

Author(s):

Shigehiro KATAYAMA ◽

Ryuzo KAWAMORI ◽

Yasuhiko IWAMOTO ◽

Ikuo SAITO ◽

Kizuku KURAMOTO

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Angiotensin Converting Enzyme ◽

Calcium Channel ◽

Angiotensin Converting Enzyme Inhibitor ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Hypertensive Patients

Download Full-text

Safety and efficacy of combination ace inhibitor/calcium channel blocker therapy versus ace inhibitor monotherapy in african american patients with hypertension and type 2 diabetes

American Journal of Hypertension ◽

10.1016/j.amjhyper.2004.03.475 ◽

2004 ◽

Vol 17 (5) ◽

pp. S180-S181 ◽

Cited By ~ 1

Author(s):

J FLACK

Keyword(s):

Type 2 Diabetes ◽

African American ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Ace Inhibitor ◽

Channel Blocker ◽

Blocker Therapy ◽

Safety And Efficacy

Download Full-text

NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study

Diabetologia ◽

10.1007/s00125-009-1608-0 ◽

2009 ◽

Vol 53 (3) ◽

pp. 510-516 ◽

Cited By ~ 11

Author(s):

A. Y. Chu ◽

J. Coresh ◽

D. E. Arking ◽

J. S. Pankow ◽

G. F. Tomaselli ◽

...

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Atherosclerosis Risk In Communities ◽

Atherosclerosis Risk ◽

Aric Study

Download Full-text

Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension

Therapeutic Advances in Cardiovascular Disease ◽

10.1177/1753944711415307 ◽

2011 ◽

Vol 5 (4) ◽

pp. 193-197 ◽

Cited By ~ 3

Author(s):

Alberto F. Rubio-Guerra ◽

Hilda Vargas-Robles ◽

German Vargas-Ayala ◽

Leticia Rodríguez-Lopez ◽

David Castro-Serna ◽

...

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Plasma Adiponectin

Download Full-text

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker

Current Medical Research and Opinion ◽

10.1185/030079907x188044 ◽

2007 ◽

Vol 23 (6) ◽

pp. 1239-1244 ◽

Cited By ~ 11

Author(s):

Effie L. Kuti ◽

William L. Baker ◽

C. Michael White

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Beta Blocker ◽

Channel Blocker ◽

Onset Type ◽

New Onset

Download Full-text

Safety and efficacy of an ACE inhibitor/calcium channel blocker combination versus an ACE inhibitor alone in hypertensive patients with type 2 diabetes

American Journal of Hypertension ◽

10.1016/s0895-7061(02)02744-9 ◽

2002 ◽

Vol 15 (4) ◽

pp. A173 ◽

Cited By ~ 1

Author(s):

G BAKRIS

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Ace Inhibitor ◽

Channel Blocker ◽

Hypertensive Patients ◽

Safety And Efficacy

Download Full-text